BURLINGTON, Mass., March 8, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado's President and CEO, will present at the 24th Annual ROTH Conference on Monday, March 12, 2012 at 9:00 AM PT. The conference will be held March 11-14, 2012 at the Ritz-Carlton, Laguna Niguel in Dana Point, CA.
